The authors concluded that available evidence demonstrates the efficacy of body weight-supported treadmill training in children with Down syndrome. Evidence of efficacy or effectiveness in paediatric spinal cord injury and cerebral palsy was very limited. The reliability of the conclusions was limited by the weak strength of the available evidence (small sample sizes and limited randomised controlled trials).
Study selection
All studies that assessed treadmill training and body weight-supported gait training used separately or in combination for individuals less than 21 years with or at risk of a motor disability affecting gait coordination or function were eligible for inclusion. Studies that included participants 21 years or older were only considered if they reported individual data or separate data or separate analyses for individuals less than 21 years. Studies with cointerventions were considered. Studies were eligible only if they focused on improving aerobic fitness or decreasing body weight through greater caloric expenditure. Other eligibility criteria were: studies that were of typically developing children; studies that used treadmills for sports-related training; and studies that addressed diminished exercise capacity because of asthma, cystic fibrosis, obesity or acute medical illness. Studies that investigated only within-session effects of different walking conditions were excluded.
Most studies included body weight support and treadmill in combination (not all treadmill studies included use of body weight support for all participants). Participants were categorised as having cerebral palsy or other central motor impairments, spinal cord injuries and Down syndrome. Locomotor training protocols varied across studies, as did settings (in-patient, outpatient, school and home), participant ages and mobility levels (full details reported in the paper).
Two authors independently selected studies for inclusion; disagreements were resolved by discussion.
Assessment of study quality
Two authors independently rated the strength of evidence using Sackett's Levels of Evidence (I to V, with I considered the highest level of evidence) and the quality of included studies using the PEDro scale (maximum score 10). Disagreements were resolved by consensus.
Data extraction
Two authors independently extracted data, where reported, on mean scores in the intervention and control groups to calculate mean change and differences in mean change scores. Effect sizes were calculated for the three most common outcome measures (self-selected gait velocity, Gross Motor Function Measure dimensions D and E) in the group with central nervous system impairments by dividing the difference in mean change scores across treatment groups by the standard deviation of the mean change score in the control group or dividing the mean change due to the intervention of interest by its standard deviation. Disagreements were resolved by consensus.
